Team:NTU-Singapore

From 2008.igem.org

(Difference between revisions)
Line 25: Line 25:
For any comments or enquiries, contact us at [mailto:ntu.igem@gmail.com ntu.igem@gmail.com]   
For any comments or enquiries, contact us at [mailto:ntu.igem@gmail.com ntu.igem@gmail.com]   
|[[Image:Xdx29.tmp.jpg|right|thumb|400px|My team]]
|[[Image:Xdx29.tmp.jpg|right|thumb|400px|My team]]
 +
|}
 +
=Upcoming important event=
 +
{|
 +
|'''1 July''' || Team project descriptions due (Early summer teams)
 +
|- 
 +
| || Team registration fee due
 +
|- 
 +
|'''1 September''' || Final team rosters due
 +
|- 
 +
|'''1 October''' || Jamboree attendance fees due; notice and description of any use of non-standard parts or devices schemes due
 +
|- 
 +
|'''15 October''' || Project Summary forms due (to allow for organization of judging)
 +
|-
 +
|'''29 October''' || Project and part documentation due
 +
|- 
 +
|'''29 October''' || BioBrick Part DNA received by the Registry
 +
|- 
 +
|'''8-9 November''' || iGEM Competition Jamboree, MIT, USA
|}
|}

Revision as of 15:00, 28 May 2008

Contents

Team background

The NTU-Singapore iGEM08 team consists of six undergraduate students working full-time from May to July 2008 . In addition, we have a number of graduate students and faculty advisors.
Our team logo

Project introduction

Our group has decided to engineer E.coli as a carrier for colicin E7 to deal with the pathogenic strain of Ecoli known as Escherichia coli O157:H7.

Escherichia coli O157:H7 is an enterohemorrhagic strain that can cause bloody diarrhea and kidney failure. Current methods of cure for the infection include blood transfusion and dialysis. Currently no antibiotic is able to kill it.

Our approach is to use Colicin E7 to kill the this harmful strain of bacteria. We intend to use our very own genetically engineered E.coli as the carrier of the colicin. We also wish for our bacteria to able to detect the presence of blood and the bacteria before it releases the colicins to eradicate the pathogen.

Our aim would be to control the level of colicin production in our bacteria. Our engineered bacteria should also be able to be accurate in its detection.

As an extension for our project, we can also investigate the dynamics of biological interactions,, i.e. mutualism, neutralism; using our engineered bacteria.

For any comments or enquiries, contact us at ntu.igem@gmail.com

My team

Upcoming important event

1 July Team project descriptions due (Early summer teams)
Team registration fee due
1 September Final team rosters due
1 October Jamboree attendance fees due; notice and description of any use of non-standard parts or devices schemes due
15 October Project Summary forms due (to allow for organization of judging)
29 October Project and part documentation due
29 October BioBrick Part DNA received by the Registry
8-9 November iGEM Competition Jamboree, MIT, USA

Visitor map

Locations of visitors to this page